Joel Gabre (@gabrejoel) 's Twitter Profile
Joel Gabre

@gabrejoel

Early Onset GI Cancer Researcher | Gastroenterologist @ Columbia/NYPH | a new New Yorker

ID: 1288963227301355522

calendar_today30-07-2020 22:22:43

77 Tweet

172 Takipçi

174 Takip Edilen

Joel Gabre (@gabrejoel) 's Twitter Profile Photo

Very cool story on how a simple question from a resident physician turned into a landmark trial in NEJM on acute pancreatitis

GI Pearls (@gi_pearls) 's Twitter Profile Photo

Now that the NEJM study is out, will the bold/unprecedented/models-based move to start colon cancer screening at 45 will be looked at again? Models change... #GITwitter #MedEd

Katie Spina (she/her) (@katie_spina) 's Twitter Profile Photo

Huge milestone today: I successfully submitted my first R01. I am feeling immensely grateful and beyond excited. As an R01 virgin, here are my take aways:

Joel Gabre (@gabrejoel) 's Twitter Profile Photo

Very important that we do more research to understand the rise of colon cancer in young adults. Happy to provide comment to CNN on this important story cnn.com/2023/03/01/hea…

Stand Up To Cancer (@su2c) 's Twitter Profile Photo

Hear from Dr. Nicolette Rodriguez (@Dr_NJRodriguez), an early career investigator with #StandUpToCancer’s Colorectal Cancer Health Equity Dream Team. If you are 45 or older, make a plan to get screened for #colorectalcancer. The best path to prevention is early detection. ❤️

CU-DLDRC (@cudldrc) 's Twitter Profile Photo

Congratulations to CU-DLDRC Member, Dr Anil Rustgi, MD and his team (including DLDRC members Drs Hiroshi Nakagawa, Joel Gabre and Jianhua Hu) on his Stand Up to Cancer Grant Award to address diverse challenges is GI research!

Herbert Irving Comprehensive Cancer Center (@columbiacancer) 's Twitter Profile Photo

RAS proteins have long been an elusive cancer drug target. New preclinical research in nature from KenOliveLab shows the potential of an entire new class of experimental drugs that could treat almost all forms of pancreatic cancer - and maybe even more. cuimc.columbia.edu/news/opening-n…

RAS proteins have long been an elusive cancer drug target. New preclinical research in <a href="/Nature/">nature</a> from <a href="/KenOliveLab/">KenOliveLab</a> shows the potential of an entire new class of experimental drugs that could treat almost all forms of pancreatic cancer - and maybe even more.
cuimc.columbia.edu/news/opening-n…
Joel Gabre (@gabrejoel) 's Twitter Profile Photo

Excited to put out a new a pre-print of our work Herbert Irving Comprehensive Cancer Center on early onset colorectal cancer. In it we leverage scRNA seq and a comp tool called VIPER to identify an inflammatory signature similar to colitis associated cancer in early onset tumors. biorxiv.org/content/10.110…